EVLO (Evelo Biosciences) Total Liabilities: $47.33 Mil (As of Sep. 2023)


What is Evelo Biosciences Total Liabilities?

Evelo Biosciences EVLO -99.00% Total Liabilities is $47.33 Mil as of Sep. 2023.

Evelo Biosciences's Total Liabilities for the quarter that ended in Sep. 2023 was $47.33 Mil.

Evelo Biosciences's quarterly Total Liabilities declined from Mar. 2023 ($69.36 Mil) to Jun. 2023 ($66.95 Mil) and declined from Jun. 2023 ($66.95 Mil) to Sep. 2023 ($47.33 Mil).

Evelo Biosciences's annual Total Liabilities increased from Dec. 2020 ($60.15 Mil) to Dec. 2021 ($79.20 Mil) but then declined from Dec. 2021 ($79.20 Mil) to Dec. 2022 ($69.43 Mil).

Evelo Biosciences Total Liabilities Historical Data

* Premium members only.

The historical data trend for Evelo Biosciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evelo Biosciences Total Liabilities Chart

Evelo Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Liabilities
Get a 7-Day Free Trial 22.92 30.72 60.15 79.20 69.43

Evelo Biosciences Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.00 69.43 69.36 66.95 47.33

Evelo Biosciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Evelo Biosciences's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=12.395+(48.879+0.65900000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+7.5+0+0)
=69.43

Total Liabilities=Total Assets (A: Dec. 2022 )-Total Equity (A: Dec. 2022 )
=64.441--4.992
=69.43

Evelo Biosciences's Total Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=39.761+(0+0.073
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+7.5+0+0)
=47.33

Total Liabilities=Total Assets (Q: Sep. 2023 )-Total Equity (Q: Sep. 2023 )
=20.627--26.707
=47.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $47.33 Mil mean?
Evelo Biosciences (EVLO) has a Total Liabilities of $47.33 Mil as of Sep. 2023. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Evelo Biosciences and its competitors.
Is Evelo Biosciences' Total Liabilities too high?
Evelo Biosciences' current Total Liabilities is $47.33 Mil.
How does Evelo Biosciences' Total Liabilities compare to IMNN and EDSA?
Evelo Biosciences' Total Liabilities of $47.33 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Evelo Biosciences and its competitors. Evelo Biosciences's current Total Liabilities is $47.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evelo Biosciences stock overvalued right now?
Evelo Biosciences (EVLO) has a current Total Liabilities of $47.33 Mil. The current Total Liabilities is $47.33 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Evelo Biosciences (EVLO), the current Total Liabilities is $47.33 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evelo Biosciences Business Description

Address 620 Memorial Drive, Cambridge, MA, USA, 02139
Evelo Biosciences Inc is a clinical-stage biotechnology company focused on discovering and developing a new class of oral medicines that act on immune cells in the small intestine with systemic effects. The company is developing EDP1815 as a treatment in psoriasis and atopic dermatitis and EDP2939 in psoriasis.